AMG-3969

N/A

Report date: 2023/09/20 10:03:12
NME

Base Information

Drug NameAMG-3969
Drug Alias NameAMG-3969
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase-glucokinase regulatory protein disruptor
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A